{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-23-002947","form_type":"8-K","ticker":"ZOMDF","cik":"0001684144","company_name":"Zomedica Corp.","filed_at":"2023-03-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.134839+00:00","generated_at":"2026-06-18T02:10:36.814614+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Zomedica reports 2022 revenue of $18.9M, up 361% YoY; net loss narrows to $17.0M","bullets":["Revenue $18.9M, up 361% from $4.1M in 2021; 72% gross margin.","Net loss $17.0M vs $18.4M in 2021; improvement of $1.4M (8%).","Cash, equivalents and securities $156M at Dec 31, 2022; no SVB/Signature exposure.","PulseVet small-animal device sales grew 405% in 2022; VetGuardian launched; TRUVIEW expected Q2 2023.","Acquisitions of Assisi and Revo Squared contributed; evaluating further M&A."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-23-002947","json":"https://secwatch.observer/filing/0001654954-23-002947.json","markdown":"https://secwatch.observer/filing/0001654954-23-002947.md","text":"https://secwatch.observer/filing/0001654954-23-002947.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1684144/000165495423002947/0001654954-23-002947-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1684144/000165495423002947/zom_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T02:10:36.814614+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}